Edit filter log

' {{notability|Biographies|date=March 2017}} {{Infobox person | name = Anthony Gill | education = | birth_date = {{birth date and age|1972|08|15}} | image = | alma_mater = University of Sydney | occupation = Professor, doctor, researcher, author | years_active = 1998 - Present | website = <!-- {{URL|example.com}} --> }} '''Anthony Gill''' is an Australian professor and researcher. He is professor of surgical pathology at the [[University of Sydney]] and the chairman of Australian Pancreatic Cancer Genome Initiative.<ref>http://www.pancreaticcancer.net.au/</ref> == Education == Gill was born in [[Sydney]] in 1972 and attended The Shore School, [[Sydney Church of England Grammar School]], on a full academic scholarship, graduating in 1990. Gill completed a combined bachelor of medicine and bachelor of surgery degree at the University of Sydney in 1996, graduating with the Harry J Clayton Memorial Prize, Hinder Memorial Prize, the Robert Scot Skirving Memorial Prize and the Royal North Shore Hospital Medal. == Career == Gill joined the [[Garvan Institute of Medical Research]] as a visiting pathologist in 2009. At the institute he was the lead anatomical pathologist for the Australian Pancreatic Cancer Genome Initiate (APGI) project to perform whole genome sequencing on 400 pancreatic cancers. In 2011, he received a higher doctorate (Doctor of Medicine) degree from University of Sydney. In 2016, he was made the chairman of Australian Pancreatic Genome Initiative (APGI) and head of the APGI research group at the Garvan Institute of Medical research. Gill has been active in research across broad areas of surgical pathology particularly endocrine and pancreaticobiliary pathology, but is best known for his research describing the surgical pathology of the tumors now known as succinate dehydrogenase deficient gastrointestinal stromal tumor (GIST) and succinate dehydrogenase deficient renal cell carcinoma.<ref name=C/><ref name=D/> In addition to allowing the recognition of these ‘new types’ of cancers, these discoveries have facilitated the early diagnosis of patients and families with hereditary cancer syndromes due to germline mutations in the components of the mitochondrial complex 2 – SDHA, SDHB, SDHC and [[SDHD]].<ref>{{cite web|url=http://www.cancerdxpathology.org.au/news.html |title=Cancer Diagnosis and Pathology}}</ref> Largely for his work in this area, Gill was awarded the Benjamin Castleman Award from the United States and Canadian Academy of Pathology (USCAP) in 2011, the NSW Premier’s Award for excellence in Translational Cancer Research from the NSW Cancer Institute in 2013 and the Sir Zelman Cowen Universities Fund Prize for Discovery in Medical Research in 2014.<ref>{{cite web|url=http://sydney.edu.au/szcuf/prize/announcements.shtml |title= Award Announcements}}</ref> As of 2016, Gill is professor of Surgical Pathology at University of Sydney, senior staff specialist at Royal North Shore Hospital, chairman of the APGI and director of the Cancer Diagnosis and Pathology Research Group.<ref>{{cite web|url=http://loop.frontiersin.org/people/307400/overview|title=Anthony J Gill }}</ref><ref>{{cite web|url=https://www.labome.org/expert/australia/university/gill/anthony-j-gill-1344658.html |title= Anthony J Gill}}</ref> == Awards and honors == *1990 - The [[Australian Students Prize]] *1994 - The Graham Coupland Prize (first in the university in the faculty of medicine) *1994 - Fagan Memorial Prize for Surgery *1995 - The Deprtment of Health Scholarship *1996- The Campbell Kordick Memorial Prize *1996 - The Harry J Clayton Memorial Prize - first in university in Medicine and Clinical Medicine *1996 - The Hinder Memorial Prize - first in university in Surgery and Clinical Surgery *1996 - The Robert Scot Skirving Memorial Prize - first in the university in Medicine and Surgery *1996 - The Royal North Shore Hospital Medal *2011 - The Benjamin Castleman Award - Awarded by the USCAP<ref>{{Cite web|url=http://www.uscap.org/about/uscap-awards/benjamin-castleman-award/|title= Benjamin Castleman Award}}</ref> *2011 - The Sir John Loewenthal Medal (awarded by the Discipline of Surgery, University of Sydney) *2012 - NSW Cancer Institute Wildfire Award *2013 - NSW Premier’s Award for Excellence in Translational Cancer Research *2014 - The Sir Zelman Cowen Universities Prize for discovery in Medical Research *2015 - NSW Cancer Institute Wildfire Award == Publications == *Gill AJ, Clarkson A, Gimm O, Keil J, Dralle H, Howell VM, Marsh DJ. Loss of nuclear expression of parafibromin distinguishes parathyroid carcinomas and Hyperparathyroidsim-Jaw Tumor (HPT-JT) syndrome related adenomas from sporadic parathyroid adenomas and hyperplasias American Journal of Surgical Pathology 2006 30:1140-1149 *Gill AJ, Chou A, Vilain R, Clarkson A, Lui M, Jin R, Tobias V, Samra J, Goldstein D, Smith C, Sioson L, Parker N, Smith RC, Sywak M, Sidhu SB, Ma Wyatt J, Robinson BG, Benn DE, Clifton-Bligh RJ Immunohistochemistry for SDHB divides Gastrointestinal Stromal Tumors (GISTs) into two distinct types American Journal of Surgical Pathology 2010;34:636-44 *Gill AJ, Benn DE, Chou A, Clarkson A, Muljono A, Meyer-Rochow G, Richardson A-L, Sidhu SB, Robinson BG, Clifton-Bligh RJ Immunohistochemistry for SDHB triages genetic testing of SDHB, SDHC and SDHD in paraganglioma-phaeochromocytoma syndromes Human Pathology 2010 41:805-814 *Gill AJ, Pachter NS, Clarkson A, Tucker KM, Winship I, Benn DE, Robinson BG, Clifton-Bligh R Renal Tumors and Hereditary Pheochromoytoma-Paraganglioma Syndrome New England Journal of Medicine 2011 364; 9:885-886 *Gill AJ, Chou A, Vilain RE, Clifton-Bligh RJ “Pediatric type” Gastrointestinal stromal tumors are SDHB negative (“type 2”) GISTs American Journal of Surgical Pathology 2011 35:1245–1247 *Gill AJ, Pachter NS, Chou A, Young B, Clarkson A, Tucker KM, Winship IM, Earls P, Benn DE, Robinson BG, Fleming S, Clifton-Bligh RH The renal tumors associated with germline SDHB mutation show distinctive morphology American Journal of Surgical Pathology 2011 35:1578-1585 *Dwight T, Benn DE, Clarkson A, Vilain R, Lipton L, Robinson BG, Clifton-Bligh RJ, Gill AJ Loss of SDHA expression identifies SDHA mutations in succinate dehydrogenase deficient gastrointestinal stromal tumors American Journal of Surgical Pathology 2013; 37:226–233 *Gill AJ, Hes O, Papathomas T, Sedivcova M, Tan PH, Agaimy A, Andresen PA, Kedziora A, Clarkson A, Toon CW, Sioson L, Watson N, Chou A, Paik J, Clifton-Bligh RJ, Robinson BG, Benn DE, Hills H, Maclean F, Niemeijer ND, Vlatkovic L, Hartmann A, Corssmit EPM, van Leenders GJLH, Pryzbycin C, McKenney JK, Magi-Galluzzi C, Yilmaz A, Yu D, Nicoll KD, Yong JL, Sibony M, Yakirevich E, Fleming S, Chow CW, Miettinen M, Michal M, Trpkov Succinate dehydrogenase (SDH) deficient renal carcinoma – a morphologically distinct entity: A clinicopathologic series of 36 tumors from 27 patients American Journal of Surgical Pathology 2014; 38:1588–1602 *Farzin M, Toon CW, Clarkson A, Sioson L, Watson N, Andrici J, Gill AJ Loss of expression of BAP1 predicts longer survival in mesothelioma Pathology 2015; 47:302-307 *Andrici J, Sheen A, Sioson L, Wardell K, Clarkson A, Watson N, Ahadi MS, Farzin M, Toon CW, Gill AJ Loss of expression of BAP1 is a useful adjunct which strongly supports the diagnosis of mesothelioma in effusion cytology Modern Pathology 2015; 28:1360–1368 *Harrison WJ, Andrici J, Maclean F, Madadi-Ghahan R, Farzin M, Sioson L, Toon CW, Clarkson A, Watson N, Pickett J, Field M, Crook A, Tucker K, Goodwin A, Anderson L, Srinivasan B, Grossman P, Martinek P, Ondic O, Hes O, Trpkov K, Clifton-Bligh RJ, Dwight T, Gill AJ Fumarate hydratase deficient uterine leiomyomas occur in both the syndromic and sporadic settings American Journal of Surgical Pathology 2016; 40:599–607 *Trpkov K, Hess O, Agaimy A, Bonert M, Martinek P, Magi-Galluzzi C, Kristiansen G, Lüders C, Nesi G, Comperat E, Sibony M, Berney DM, Mehra R, Brimo F, Hartman A, Husain A, Frizzell N, Hills K, Maclean F, Srinivasan B, Gill AJ Fumarate Hydratase-deficient Renal Cell Carcinoma is Strongly Correlated with Fumarate Hydratase Mutation and Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome American Journal of Surgical Pathology 2016;40:865–875 == References == {{reflist}} [[Category:University of Sydney alumni]] [[Category:University of Sydney faculty]] [[Category:Australian pathologists]] [[Category:1972 births]] [[Category:Living people]]'